{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T05:28:28Z","timestamp":1786339708937,"version":"build-2736575974"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-026-02247-4","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:53:09Z","timestamp":1785448389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of sarcopenic obesity with advanced cardiovascular-kidney-metabolic syndrome and incident cardiovascular disease: a longitudinal and cross-sectional study"],"prefix":"10.1186","volume":"18","author":[{"given":"Roushan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"issue":"10191","key":"2247_CR1","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/s0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Sayer AA. Sarcopenia Lancet. 2019;393(10191):2636\u201346. https:\/\/doi.org\/10.1016\/s0140-6736(19)31138-9.","journal-title":"Sarcopenia Lancet"},{"issue":"3","key":"2247_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"LK Chen","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300\u2013e3072. https:\/\/doi.org\/10.1016\/j.jamda.2019.12.012.","journal-title":"J Am Med Dir Assoc"},{"issue":"9","key":"2247_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","volume":"14","author":"JA Batsis","year":"2018","unstructured":"Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018;14(9):513\u201337. https:\/\/doi.org\/10.1038\/s41574-018-0062-9.","journal-title":"Nat Rev Endocrinol"},{"issue":"25 Suppl 2","key":"2247_CR4","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","volume":"129","author":"MD Jensen","year":"2014","unstructured":"Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102\u201338. https:\/\/doi.org\/10.1161\/01.cir.0000437739.71477.ee.","journal-title":"Circulation"},{"issue":"10046","key":"2247_CR5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/s0140-6736(16)30175-1","volume":"388","author":"BMIMC Global","year":"2016","unstructured":"Global BMIMC, Di Angelantonio E, Bhupathiraju Sh N, Wormser D, Gao P, Kaptoge S, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776\u201386. https:\/\/doi.org\/10.1016\/s0140-6736(16)30175-1.","journal-title":"Lancet"},{"key":"2247_CR6","doi-asserted-by":"publisher","unstructured":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 2004. 363(9403): pp. 157\u201363. https:\/\/doi.org\/10.1016\/s0140-6736(03)15268-3","DOI":"10.1016\/s0140-6736(03)15268-3"},{"issue":"6","key":"2247_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/MCO.0b013e328312c37d","volume":"11","author":"S Stenholm","year":"2008","unstructured":"Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care. 2008;11(6):693\u2013700. https:\/\/doi.org\/10.1097\/MCO.0b013e328312c37d.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"6","key":"2247_CR8","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/oby.2004.107","volume":"12","author":"R Roubenoff","year":"2004","unstructured":"Roubenoff R. Sarcopenic obesity: the confluence of two epidemics. Obes Res. 2004;12(6):887\u20138. https:\/\/doi.org\/10.1038\/oby.2004.107.","journal-title":"Obes Res"},{"issue":"21","key":"2247_CR9","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/cir.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, Despr\u00e9s JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143(21):e984\u20131010. https:\/\/doi.org\/10.1161\/cir.0000000000000973.","journal-title":"Circulation"},{"issue":"16","key":"2247_CR10","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/circulationaha.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640\u20135. https:\/\/doi.org\/10.1161\/circulationaha.109.192644.","journal-title":"Circulation"},{"key":"2247_CR11","doi-asserted-by":"publisher","unstructured":"Hong SH, Choi KM. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. Int J Mol Sci. 2020;21(2). https:\/\/doi.org\/10.3390\/ijms21020494.","DOI":"10.3390\/ijms21020494"},{"key":"2247_CR12","doi-asserted-by":"publisher","unstructured":"Nair KS. Aging muscle2, 3, 4. The American Journal of Clinical Nutrition, 2005. 81(5): pp. 953\u201363. https:\/\/doi.org\/10.1093\/ajcn\/81.5.953","DOI":"10.1093\/ajcn\/81.5.953"},{"issue":"4","key":"2247_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412\u201323. https:\/\/doi.org\/10.1093\/ageing\/afq034.","journal-title":"Age Ageing"},{"issue":"5","key":"2247_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/gerona\/glu013","volume":"69","author":"TT Dam","year":"2014","unstructured":"Dam TT, Peters KW, Fragala M, Cawthon PM, Harris TB, McLean R, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol Biol Sci Med Sci. 2014;69(5):584\u201390. https:\/\/doi.org\/10.1093\/gerona\/glu013.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"5","key":"2247_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-023-00943-z","volume":"20","author":"CM Prado","year":"2024","unstructured":"Prado CM, Batsis JA, Donini LM, Gonzalez MC, Siervo M. Sarcopenic obesity in older adults: a clinical overview. Nat Rev Endocrinol. 2024;20(5):261\u201377. https:\/\/doi.org\/10.1038\/s41574-023-00943-z.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2247_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13395-022-00309-5","volume":"12","author":"DJ Murdock","year":"2022","unstructured":"Murdock DJ, Wu N, Grimsby JS, Calle RA, Donahue S, Glass DJ, et al. The prevalence of low muscle mass associated with obesity in the USA. Skelet Muscle. 2022;12(1):26. https:\/\/doi.org\/10.1186\/s13395-022-00309-5.","journal-title":"Skelet Muscle"},{"issue":"3","key":"2247_CR17","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.clnu.2024.02.002","volume":"43","author":"M Jiang","year":"2024","unstructured":"Jiang M, Ren X, Han L, Zheng X. Associations between sarcopenic obesity and risk of cardiovascular disease: A population-based cohort study among middle-aged and older adults using the CHARLS. Clin Nutr. 2024;43(3):796\u2013802. https:\/\/doi.org\/10.1016\/j.clnu.2024.02.002.","journal-title":"Clin Nutr"},{"issue":"10","key":"2247_CR18","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1017\/s0007114520002172","volume":"124","author":"JL Atkins","year":"2020","unstructured":"Atkins JL, Wannamathee SG. Sarcopenic obesity in ageing: cardiovascular outcomes and mortality. Br J Nutr. 2020;124(10):1102\u201313. https:\/\/doi.org\/10.1017\/s0007114520002172.","journal-title":"Br J Nutr"},{"issue":"2","key":"2247_CR19","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/oby.21356","volume":"24","author":"J Ma","year":"2016","unstructured":"Ma J, Hwang SJ, McMahon GM, Curhan GC, McLean RR, Murabito JM, et al. Mid-adulthood cardiometabolic risk factor profiles of sarcopenic obesity. Obes (Silver Spring). 2016;24(2):526\u201334. https:\/\/doi.org\/10.1002\/oby.21356.","journal-title":"Obes (Silver Spring)"},{"issue":"1","key":"2247_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.archger.2014.03.012","volume":"59","author":"EP dos Santos","year":"2014","unstructured":"dos Santos EP, Gadelha AB, Safons MP, N\u00f3brega OT, Oliveira RJ, Lima RM. Sarcopenia and sarcopenic obesity classifications and cardiometabolic risks in older women. Arch Gerontol Geriatr. 2014;59(1):56\u201361. https:\/\/doi.org\/10.1016\/j.archger.2014.03.012.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"2247_CR21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/jcsm.12877","volume":"13","author":"PC Yu","year":"2022","unstructured":"Yu PC, Hsu CC, Lee WJ, Liang CK, Chou MY, Lin MH, et al. Muscle-to-fat ratio identifies functional impairments and cardiometabolic risk and predicts outcomes: biomarkers of sarcopenic obesity. J Cachexia Sarcopenia Muscle. 2022;13(1):368\u201376. https:\/\/doi.org\/10.1002\/jcsm.12877.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"2247_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3346\/jkms.2015.30.3.264","volume":"30","author":"JH Kim","year":"2015","unstructured":"Kim JH, Cho JJ, Park YS. Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the Framingham risk score. J Korean Med Sci. 2015;30(3):264\u201371. https:\/\/doi.org\/10.3346\/jkms.2015.30.3.264.","journal-title":"J Korean Med Sci"},{"issue":"20","key":"2247_CR23","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/cir.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023;148(20):1606\u201335. https:\/\/doi.org\/10.1161\/cir.0000000000001184.","journal-title":"Circulation"},{"issue":"21","key":"2247_CR24","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011\u20132020. JAMA. 2024;331(21):1858\u201360. https:\/\/doi.org\/10.1001\/jama.2024.6892.","journal-title":"JAMA"},{"key":"2247_CR25","doi-asserted-by":"publisher","first-page":"1623766","DOI":"10.3389\/fnut.2025.1623766","volume":"12","author":"Y Chen","year":"2025","unstructured":"Chen Y, Tu H, Liang M, Shen M. Association between body roundness index and advanced cardiovascular-kidney-metabolic syndrome. Front Nutr. 2025;12:1623766. https:\/\/doi.org\/10.3389\/fnut.2025.1623766.","journal-title":"Front Nutr"},{"issue":"1","key":"2247_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s13098-025-01943-x","volume":"17","author":"D Zooravar","year":"2025","unstructured":"Zooravar D. Sarcopenia (defined by low muscle mass) as a predictor of disease progression and mortality in cardiovascular-kidney-metabolic syndrome. Diabetol Metab Syndr. 2025;17(1):391. https:\/\/doi.org\/10.1186\/s13098-025-01943-x.","journal-title":"Diabetol Metab Syndr"},{"key":"2247_CR27","doi-asserted-by":"publisher","first-page":"101060","DOI":"10.1016\/j.ajpc.2025.101060","volume":"23","author":"Y Wei","year":"2025","unstructured":"Wei Y, Hu X. Sarcopenia and cardiovascular disease among adults with cardiovascular-kidney-metabolic syndrome stages 0\u20133: A prospective cohort study. Am J Prev Cardiol. 2025;23:101060. https:\/\/doi.org\/10.1016\/j.ajpc.2025.101060.","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"2247_CR28","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s13098-025-02032-9","volume":"17","author":"Y Xin","year":"2025","unstructured":"Xin Y, Qian X, Yang Y. Associations between sarcopenic obesity and the risk of cardiovascular-kidney-metabolic syndrome progression: insights from the China health and retirement longitudinal study. Diabetol Metab Syndr. 2025;17(1):460. https:\/\/doi.org\/10.1186\/s13098-025-02032-9.","journal-title":"Diabetol Metab Syndr"},{"issue":"16","key":"2247_CR29","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/cir.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, et al. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation. 2019;139(16):e840\u201378. https:\/\/doi.org\/10.1161\/cir.0000000000000664.","journal-title":"Circulation"},{"issue":"7","key":"2247_CR30","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa1800256","volume":"379","author":"A Rawshani","year":"2018","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, Sattar N, Eliasson B, Svensson AM, et al. Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2018;379(7):633\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1800256.","journal-title":"N Engl J Med"},{"issue":"20","key":"2247_CR31","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1161\/circulationaha.120.046783","volume":"142","author":"AK Wright","year":"2020","unstructured":"Wright AK, Suarez-Ortegon MF, Read SH, Kontopantelis E, Buchan I, Emsley R, et al. Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings. Circulation. 2020;142(20):1925\u201336. https:\/\/doi.org\/10.1161\/circulationaha.120.046783.","journal-title":"Circulation"},{"issue":"7","key":"2247_CR32","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1681\/asn.0000000637","volume":"36","author":"SE Claudel","year":"2025","unstructured":"Claudel SE, Schmidt IM, Waikar SS, Verma A. Cumulative Incidence of Mortality Associated with Cardiovascular-Kidney-Metabolic (CKM) Syndrome. J Am Soc Nephrol. 2025;36(7):1343\u201351. https:\/\/doi.org\/10.1681\/asn.0000000637.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2247_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138. https:\/\/doi.org\/10.1093\/ije\/dys203.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"2247_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"L-K Chen","year":"2020","unstructured":"Chen L-K, Woo J, Assantachai P, Auyeung T-W, Chou M-Y, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300\u2013e3072. https:\/\/doi.org\/10.1016\/j.jamda.2019.12.012.","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"2247_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/jcsm.12163","volume":"8","author":"M Yang","year":"2017","unstructured":"Yang M, Hu X, Wang H, Zhang L, Hao Q, Dong B. Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: a prospective study. J Cachexia Sarcopenia Muscle. 2017;8(2):251\u20138. https:\/\/doi.org\/10.1002\/jcsm.12163.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2247_CR36","doi-asserted-by":"publisher","first-page":"101264","DOI":"10.1016\/j.eclinm.2021.101264","volume":"44","author":"K Gao","year":"2022","unstructured":"Gao K, Cao LF, Ma WZ, Gao YJ, Luo MS, Zhu J, et al. Association between sarcopenia and cardiovascular disease among middle-aged and older adults: Findings from the China health and retirement longitudinal study. EClinicalMedicine. 2022;44:101264. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101264.","journal-title":"EClinicalMedicine"},{"issue":"6","key":"2247_CR37","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1002\/jcsm.13081","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Peng W, Ren R, Wang Y, Wang G. Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLS. J Cachexia Sarcopenia Muscle. 2022;13(6):2944\u201352. https:\/\/doi.org\/10.1002\/jcsm.13081.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"2247_CR38","first-page":"551","volume":"20","author":"X Wen","year":"2011","unstructured":"Wen X, Wang M, Jiang CM, Zhang YM. Anthropometric equation for estimation of appendicular skeletal muscle mass in Chinese adults. Asia Pac J Clin Nutr. 2011;20(4):551\u20136.","journal-title":"Asia Pac J Clin Nutr"},{"issue":"8","key":"2247_CR39","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s12603-014-0540-2","volume":"18","author":"TdS Alexandre","year":"2014","unstructured":"Alexandre TdS, Duarte YADO, Santos JLF, Wong R, Lebrao ML. Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus dynapenia as a risk factor for mortality in the elderly. J Nutr health aging. 2014;18(8):751\u20136. https:\/\/doi.org\/10.1007\/s12603-014-0540-2.","journal-title":"J Nutr health aging"},{"issue":"5","key":"2247_CR40","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1111\/dom.15506","volume":"26","author":"WJ Tu","year":"2024","unstructured":"Tu WJ, Zhao Z, Yan F, Zeng X, Li J. Geographic and ethnicity variation in the prevalence of middle-aged and elderly adult obesity in China in 2020. Diabetes Obes Metab. 2024;26(5):1897\u2013907. https:\/\/doi.org\/10.1111\/dom.15506.","journal-title":"Diabetes Obes Metab"},{"key":"2247_CR41","doi-asserted-by":"publisher","unstructured":"Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci, 2014. 69(5): pp. 547\u2009\u2013\u200958. https:\/\/doi.org\/10.1093\/gerona\/glu010","DOI":"10.1093\/gerona\/glu010"},{"key":"2247_CR42","doi-asserted-by":"publisher","first-page":"113003","DOI":"10.1016\/j.exger.2025.113003","volume":"213","author":"Y Chen","year":"2026","unstructured":"Chen Y, Huang T, Wang J, Guo C, Gao J, Feng X. Association between C-reactive protein-triglyceride glucose index and risk of sarcopenia in older adults: findings from CHARLS and NHANES. Exp Gerontol. 2026;213:113003. https:\/\/doi.org\/10.1016\/j.exger.2025.113003.","journal-title":"Exp Gerontol"},{"key":"2247_CR43","doi-asserted-by":"publisher","unstructured":"Yin H, Ma Y, Liu X, Liu C, Dong T, Kong L, et al. Diabetes-related foot disease and sarcopenia-related traits: evidence from US and Chinese cohorts and mendelian randomization. Aging Clin Exp Res. 2026;38(1). https:\/\/doi.org\/10.1007\/s40520-026-03342-2.","DOI":"10.1007\/s40520-026-03342-2"},{"key":"2247_CR44","doi-asserted-by":"publisher","unstructured":"Khan SS, Matsushita K, Sang Y, et al. Development and Validation of the American Heart AssociationPredicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations. Circulation. 2024;149(6):430\u2013449. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.067626.","DOI":"10.1161\/CIRCULATIONAHA.123.067626"},{"issue":"20","key":"2247_CR45","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023;148(20):1606\u201335. https:\/\/doi.org\/10.1161\/CIR.0000000000001184.","journal-title":"Circulation"},{"issue":"3","key":"2247_CR46","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.clnu.2024.02.002","volume":"43","author":"M Jiang","year":"2024","unstructured":"Jiang M, Ren X, Han L, Zheng X. Associations between sarcopenic obesity and risk of cardiovascular disease: A population-based cohort study among middle-aged and older adults using the CHARLS. Clin Nutr. 2024;43(3):796\u2013802. https:\/\/doi.org\/10.1016\/j.clnu.2024.02.002.","journal-title":"Clin Nutr"},{"issue":"2","key":"2247_CR47","doi-asserted-by":"publisher","first-page":"e13534","DOI":"10.1111\/obr.13534","volume":"24","author":"C Liu","year":"2023","unstructured":"Liu C, Wong PY, Chung YL, Chow SK, Cheung WH, Law SW, et al. Deciphering the obesity paradox in the elderly: A systematic review and meta-analysis of sarcopenic obesity. Obes Rev. 2023;24(2):e13534. https:\/\/doi.org\/10.1111\/obr.13534.","journal-title":"Obes Rev"},{"issue":"2","key":"2247_CR48","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.clnu.2020.06.003","volume":"40","author":"MF Xia","year":"2021","unstructured":"Xia MF, Chen LY, Wu L, Ma H, Li XM, Li Q, et al. Sarcopenia, sarcopenic overweight\/obesity and risk of cardiovascular disease and cardiac arrhythmia: A cross-sectional study. Clin Nutr. 2021;40(2):571\u201380. https:\/\/doi.org\/10.1016\/j.clnu.2020.06.003.","journal-title":"Clin Nutr"},{"issue":"9","key":"2247_CR49","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s12603-014-0553-x","volume":"18","author":"S Park","year":"2014","unstructured":"Park S, Ham JO, Lee BK. A positive association between stroke risk and sarcopenia in men aged\u2009\u2265\u200950 years, but not women: results from the Korean National Health and Nutrition Examination Survey 2008\u20132010. J Nutr Health Aging. 2014;18(9):806\u201312. https:\/\/doi.org\/10.1007\/s12603-014-0553-x.","journal-title":"J Nutr Health Aging"},{"issue":"3","key":"2247_CR50","doi-asserted-by":"publisher","first-page":"e60119","DOI":"10.1371\/journal.pone.0060119","volume":"8","author":"SO Chin","year":"2013","unstructured":"Chin SO, Rhee SY, Chon S, Hwang YC, Jeong IK, Oh S, et al. Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009. PLoS ONE. 2013;8(3):e60119. https:\/\/doi.org\/10.1371\/journal.pone.0060119.","journal-title":"PLoS ONE"},{"issue":"3","key":"2247_CR51","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/cphy.c190029","volume":"10","author":"KE Merz","year":"2020","unstructured":"Merz KE, Thurmond DC. Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake. Compr Physiol. 2020;10(3):785\u2013809. https:\/\/doi.org\/10.1002\/cphy.c190029.","journal-title":"Compr Physiol"},{"key":"2247_CR52","doi-asserted-by":"publisher","unstructured":"Tero-Vescan A, Degens H, Matsakas A, \u0218tef\u0103nescu R, \u0150sz BE, Slevin M. Exercise-Induced Muscle-Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging. Pharmaceuticals (Basel). 2025;18(8). https:\/\/doi.org\/10.3390\/ph18081222.","DOI":"10.3390\/ph18081222"},{"key":"2247_CR53","doi-asserted-by":"publisher","unstructured":"Zamboni M, Mazzali G, Brunelli A, Saatchi T, Urbani S, Giani A, et al. The Role of Crosstalk between Adipose Cells and Myocytes in the Pathogenesis of Sarcopenic Obesity in the Elderly. Cells. 2022;11(21). https:\/\/doi.org\/10.3390\/cells11213361.","DOI":"10.3390\/cells11213361"},{"issue":"9","key":"2247_CR54","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00424-020-02417-x","volume":"472","author":"A Chadt","year":"2020","unstructured":"Chadt A, Al-Hasani H. Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease. Pflugers Arch. 2020;472(9):1273\u201398. https:\/\/doi.org\/10.1007\/s00424-020-02417-x.","journal-title":"Pflugers Arch"},{"issue":"2","key":"2247_CR55","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.2337\/dc09-S302","volume":"32","author":"RA DeFronzo","year":"2009","unstructured":"DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;32(2):S157\u201363. https:\/\/doi.org\/10.2337\/dc09-S302.","journal-title":"Diabetes Care"},{"key":"2247_CR56","doi-asserted-by":"publisher","unstructured":"Nishikawa H, Asai A, Fukunishi S, Nishiguchi S, Higuchi K. Metabolic Syndrome Sarcopenia Nutrients. 2021;13(10). https:\/\/doi.org\/10.3390\/nu13103519.","DOI":"10.3390\/nu13103519"},{"issue":"13","key":"2247_CR57","doi-asserted-by":"publisher","first-page":"e011638","DOI":"10.1161\/jaha.118.011638","volume":"8","author":"RE Farmer","year":"2019","unstructured":"Farmer RE, Mathur R, Schmidt AF, Bhaskaran K, Fatemifar G, Eastwood SV, et al. Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank. J Am Heart Assoc. 2019;8(13):e011638. https:\/\/doi.org\/10.1161\/jaha.118.011638.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"2247_CR58","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/jgs.12652","volume":"62","author":"JL Atkins","year":"2014","unstructured":"Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. 2014;62(2):253\u201360. https:\/\/doi.org\/10.1111\/jgs.12652.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"2247_CR59","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s12603-009-0084-z","volume":"13","author":"WC Stephen","year":"2009","unstructured":"Stephen WC, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging. 2009;13(5):460\u20136. https:\/\/doi.org\/10.1007\/s12603-009-0084-z.","journal-title":"J Nutr Health Aging"},{"issue":"6","key":"2247_CR60","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/jcsm.13564","volume":"15","author":"Y Setoyama","year":"2024","unstructured":"Setoyama Y, Honda T, Tajimi T, Sakata S, Oishi E, Furuta Y, et al. Association between dynapenic obesity and risk of cardiovascular disease: The Hisayama study. J Cachexia Sarcopenia Muscle. 2024;15(6):2338\u201348. https:\/\/doi.org\/10.1002\/jcsm.13564.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2247_CR61","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.hcr.0000265014.36587.dd","volume":"27","author":"YH Lee","year":"2007","unstructured":"Lee YH, Pratley RE. Abdominal obesity and cardiovascular disease risk: the emerging role of the adipocyte. J Cardiopulm Rehabil Prev. 2007;27(1):2\u201310. https:\/\/doi.org\/10.1097\/01.hcr.0000265014.36587.dd.","journal-title":"J Cardiopulm Rehabil Prev"},{"issue":"9468","key":"2247_CR62","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/s0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415\u201328. https:\/\/doi.org\/10.1016\/s0140-6736(05)66378-7.","journal-title":"Lancet"},{"key":"2247_CR63","doi-asserted-by":"publisher","first-page":"631230","DOI":"10.3389\/fgene.2021.631230","volume":"12","author":"W Li","year":"2021","unstructured":"Li W, Wen S, Wu J, Zeng B, Chen T, Luo J, et al. Comparative Analysis of MicroRNA Expression Profiles Between Skeletal Muscle- and Adipose-Derived Exosomes in Pig. Front Genet. 2021;12:631230. https:\/\/doi.org\/10.3389\/fgene.2021.631230.","journal-title":"Front Genet"},{"key":"2247_CR64","doi-asserted-by":"publisher","unstructured":"Qin M, Xing L, Wu J, Wen S, Luo J, Chen T, et al. Skeletal Muscle-Derived Exosomal miR-146a-5p Inhibits Adipogenesis by Mediating Muscle-Fat Axis and Targeting GDF5-PPAR\u03b3 Signaling. Int J Mol Sci. 2023;24(5). https:\/\/doi.org\/10.3390\/ijms24054561.","DOI":"10.3390\/ijms24054561"},{"key":"2247_CR65","doi-asserted-by":"publisher","unstructured":"Luo J, Pu Q, Wu X. Recent Advances of Exosomes Derived from Skeletal Muscle and Crosstalk with Other Tissues. Int J Mol Sci. 2024;25(20). https:\/\/doi.org\/10.3390\/ijms252010877.","DOI":"10.3390\/ijms252010877"},{"key":"2247_CR66","doi-asserted-by":"publisher","first-page":"p204164","DOI":"10.1155\/2013\/204164","volume":"2013","author":"K Sakuma","year":"2013","unstructured":"Sakuma K, Yamaguchi A. Sarcopenic obesity and endocrinal adaptation with age. Int J Endocrinol. 2013;2013:p204164. https:\/\/doi.org\/10.1155\/2013\/204164.","journal-title":"Int J Endocrinol"},{"issue":"5","key":"2247_CR67","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/ajcn\/81.5.953","volume":"81","author":"KS Nair","year":"2005","unstructured":"Nair KS. Aging muscle. Am J Clin Nutr. 2005;81(5):953\u201363. https:\/\/doi.org\/10.1093\/ajcn\/81.5.953.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"2247_CR68","doi-asserted-by":"publisher","first-page":"e3502","DOI":"10.1002\/dmrr.3502","volume":"38","author":"JL Silveira Rossi","year":"2022","unstructured":"Silveira Rossi JL, Barbalho SM, Reverete de Araujo R, Bechara MD, Sloan KP, Sloan LA. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors. Diabetes Metab Res Rev. 2022;38(3):e3502. https:\/\/doi.org\/10.1002\/dmrr.3502.","journal-title":"Diabetes Metab Res Rev"},{"key":"2247_CR69","doi-asserted-by":"publisher","first-page":"1661826","DOI":"10.3389\/fnut.2025.1661826","volume":"12","author":"C Pengfei","year":"2025","unstructured":"Pengfei C, Lui M, Zhang L, Chen C, Wang T, Ailin H, et al. Association of SII and SIRI with incidence of cardiovascular disease in cardiovascular-kidney-metabolic syndrome: a prospective cohort study. Front Nutr. 2025;12:1661826. https:\/\/doi.org\/10.3389\/fnut.2025.1661826.","journal-title":"Front Nutr"},{"key":"2247_CR70","doi-asserted-by":"publisher","first-page":"1183200","DOI":"10.3389\/fpubh.2023.1183200","volume":"11","author":"Y Peng","year":"2023","unstructured":"Peng Y, Li H, Liao F, Lu J, Yang W, Tan L, et al. Association between weight change and the predicted 10-year risk for atherosclerosis cardiovascular disease among U.S. older adults: data from National Health and Nutrition Examination Survey 1999\u20132018. Front Public Health. 2023;11:1183200. https:\/\/doi.org\/10.3389\/fpubh.2023.1183200.","journal-title":"Front Public Health"},{"key":"2247_CR71","doi-asserted-by":"publisher","first-page":"1660210","DOI":"10.3389\/fendo.2025.1660210","volume":"16","author":"H Zhou","year":"2025","unstructured":"Zhou H, Xing Y, Wang T, Wang T, Xierzhati S, Adili D, et al. Novel adiposity indices and their associations with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: findings from a nationwide prospective cohort study. Front Endocrinol (Lausanne). 2025;16:1660210. https:\/\/doi.org\/10.3389\/fendo.2025.1660210.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02247-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02247-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02247-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:43:44Z","timestamp":1786337024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02247-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2247"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02247-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8814645\/v1","asserted-by":"object"}]},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The CHARLS study was approved by the Biomedical Ethics Review Committee of Peking University (Approval No.: IRB00001052-11015). The NHANES protocol was approved by the National Center for Health Statistics (NCHS) Research Ethics Review Board. Informed consent was obtained from all individual participants included in the study. Informed consent was obtained from all subjects involved in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"170"}}